title: Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement.
authors.forename: Qurrat-Ul-Ain
authors.initials: QU
authors.lastname: Nawab
authors.forename: Emmel
authors.initials: E
authors.lastname: Golden
authors.forename: Marco
authors.initials: M
authors.lastname: Confalonieri
authors.forename: Reba
authors.initials: R
authors.lastname: Umberger
authors.forename: G Umberto
authors.initials: GU
authors.lastname: Meduri
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000187:drug effects; D017714:Community-Acquired Infections / Q000188:drug therapy*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D017063:Outcome Assessment, Health Care; D011014:Pneumonia / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000305:Adrenal Cortex Hormones; D002097:C-Reactive Protein; D008775:Methylprednisolone